SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) will host its seventh annual R&D Day on Thursday, December 1, 2011, from 9:30 a.m. EST / 6:30 a.m. PST to 2:00 p.m. EST / 11:00 a.m. PST, in New York. During the event, Exelixis management will review the clinical development program for cabozantinib and discuss the company’s corporate strategy and financial outlook for 2012.
